30 June 2020: Articles
Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma
Unusual clinical course, Unusual or unexpected effect of treatment, Rare disease
Il Seok Daniel Jeong A , Justin Moyers A* , Irene Thung D , Mie Mie Thinn ADOI: 10.12659/AJCR.925181
Am J Case Rep 2020; 21:e925181
Figure 2. (A) Pretreatment PET/CT and brain MRI showing pleural effusion, mediastinal adenopathy, and bony, liver, and cerebellar metastases. (B) PET/CT after 6 months of treatment showing good partial response to treatment with near resolution of pleural effusion, chest adenopathy, and bony metastases with shrinking of cerebellar metastasis.